Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study

被引：20

作者：

Georgakopoulos, Jorge R. ^{[1
]}

Felfeli, Tina ^{[2
,3
]}

Drucker, Aaron M. ^{[1
,3
,4
]}

Jo, Christine E. ^{[5
]}

Piguet, Vincent ^{[1
,4
]}

Yeung, Jensen ^{[1
,6
,7
,8
]}

机构：

[1] Univ Toronto, Dept Med, Div Dermatol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada

[2] Univ Toronto, Dept Ophthalmol & Vis Sci, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada

[3] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada

[4] Womens Coll Hosp, Toronto, ON, Canada

[5] Univ Ottawa, Fac Med, Ottawa, ON, Canada

[6] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[7] Prob Med Res Inc, Waterloo, ON, Canada

[8] Womens Coll Hosp, Dept Dermatol, 76 Grenville St,Fifth Floor, Toronto, ON M5S 1B2, Canada

来源：

JAAD INTERNATIONAL | 2021年 / 4卷

关键词：

adverse event; atopic dermatitis; drug survival; dupilumab; efficacy; safety;

D O I：

10.1016/j.jdin.2021.06.001

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：67 / 69

页数：3

共 50 条

[21] Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study
Berna-Rico, Emilio
Fiz-Benito, Esther
Busto-Leis, Jose Manuel
Servera-Negre, Guillermo
de Lucas-Laguna, Raul
Feito-Rodriguez, Marta
DERMATOLOGY, 2024, 240 (02) : 337 - 342
[22] Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
Eichenfield, Lawrence F.
Armstrong, April
Guttman-Yassky, Emma
Lio, Peter A.
Chen, Chi-Chang
Hines, Dionne M.
McGuiness, Catherine B.
Ganguli, Sohini
Delevry, Dimittri
Sierka, Debra
Mallya, Usha G.
DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1337 - 1350
[23] Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real-World Study on Effectiveness and Safety in Dupilumab Nonresponders
Zhao, Mutong
Zhuang, Yi
Liang, Yuan
Ma, Lin
Shen, Chunping
CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (09) : 694 - 696
[24] Real-world efficacy of dupilumab re-administration after discontinuation in patients with atopic dermatitis
Matsutani, Masako
Imai, Yasutomo
Miyamoto, Shoko
Inoue, Yukako
Natsuaki, Masaru
Kanazawa, Nobuo
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2024, 7
[25] One-Year Effectiveness and Safety of Dupilumab Treatment for Moderate- to-Severe Atopic Dermatitis in Korean Patients: A Real-World Retrospective Analysis
Lee, Hanjae
Kim, Bo Ri
Kim, Kyu Han
Lee, Dong Hun
Na, Jung Im
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2022, 14 (01) : 117 - 122
[26] A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbidities
Metko, Dea
Alkofide, Maha
Abu-Hilal, Mohannad
JAAD INTERNATIONAL, 2024, 15 : 5 - 11
[27] Dupilumab Monthly Dose De-Escalation Maintains Efficacy in CRSwNP: A Two-Year Real-World Study
De Corso, Eugenio
Montuori, Claudio
De Maio, Gabriele
D'Auria, Leandro Maria
Rizzuti, Alberta
Pacilli, Maria Clara
D'Agostino, Giuseppe
Mastrapasqua, Rodolfo
Mele, Dario Antonio
Galli, Jacopo
LARYNGOSCOPE, 2025,
[28] Real-World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single-Center Prospective Study
Li, Zheng
Wang, Yu
Wu, Yuemeng
Yin, Huibin
Wang, Shangshang
Wu, Hao
Qin, Haihong
Wang, Ce
Yao, Xu
Li, Wei
Gu, Chaoying
ALLERGY, 2025,
[29] Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Eric L. Simpson
Ben Lockshin
Lara Wine Lee
Zhen Chen
Moataz Daoud
Andrew Korotzer
Dermatology and Therapy, 2024, 14 : 261 - 270
[30] Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Simpson, Eric L.
Lockshin, Ben
Lee, Lara Wine
Chen, Zhen
Daoud, Moataz
Korotzer, Andrew
DERMATOLOGY AND THERAPY, 2024, 14 (01) : 261 - 270

← 1 2 3 4 5 →